Teva settles patent litigation with AstraZeneca related to diabetes drug

The settlement allows Teva to commercialise its generic version of AstraZeneca's Byetta (exenatide injection) in the US beginning October 15, 2017

Teva has settled the patent litigation with AstraZeneca related to AstraZeneca’s diabetes drug Byetta (exenatide) and entered into a settlement and license agreement with AstraZeneca, pursuant to which AstraZeneca granted a license to Teva to manufacture and commercialise the generic version of Byetta in the US. Byetta (exenatide injection) is an injectable product used to treat type 2 diabetes.

The settlement allows Teva to commercialise its generic version of Byetta (exenatide injection) in the US beginning October 15, 2017 or earlier under certain circumstances. All other terms of the agreement are confidential.

image
Business Standard
177 22
Business Standard

A COMMERCIAL FEATURE

What's this ?

Commercial Feature is a Business Standard Digital Marketing Initiative.

The Editorial/Content team at Business Standard has not contributed to writing or editing these articles.

For further information, please write to assist@bsmail.in

Teva settles patent litigation with AstraZeneca related to diabetes drug

The settlement allows Teva to commercialise its generic version of AstraZeneca's Byetta (exenatide injection) in the US beginning October 15, 2017

Topics
Pharmaceuticals

BS B2B Bureau  |  Jerusalem, Israel 

Teva Pharmaceuticals has settled the patent litigation with AstraZeneca related to AstraZeneca’s diabetes drug Byetta (exenatide) and entered into a settlement and license agreement with AstraZeneca, pursuant to which AstraZeneca granted a license to Teva to manufacture and commercialise the generic version of Byetta in the US. Byetta (exenatide injection) is an injectable product used to treat type 2 diabetes. The settlement allows Teva to commercialise its generic version of Byetta (exenatide injection) in the US beginning October 15, 2017 or earlier under certain circumstances. All ...

Teva settles patent litigation with AstraZeneca related to diabetes drug

The settlement allows Teva to commercialise its generic version of AstraZeneca's Byetta (exenatide injection) in the US beginning October 15, 2017

The settlement allows Teva to commercialise its generic version of AstraZeneca's Byetta (exenatide injection) in the US beginning October 15, 2017

Teva has settled the patent litigation with AstraZeneca related to AstraZeneca’s diabetes drug Byetta (exenatide) and entered into a settlement and license agreement with AstraZeneca, pursuant to which AstraZeneca granted a license to Teva to manufacture and commercialise the generic version of Byetta in the US. Byetta (exenatide injection) is an injectable product used to treat type 2 diabetes.

The settlement allows Teva to commercialise its generic version of Byetta (exenatide injection) in the US beginning October 15, 2017 or earlier under certain circumstances. All other terms of the agreement are confidential.

image
Business Standard
177 22

Notice: Undefined property: stdClass::$canonicalUrl in /usr2/unibs/application/modules/article/controllers/ManagerController.php on line 449

Notice: Undefined index: seconddigit in /usr2/unibs/library/Site/Article/Processor.php on line 183

Notice: Undefined index: seconddigit in /usr2/unibs/library/Site/Article/Processor.php on line 183

Notice: Undefined index: seconddigit in /usr2/unibs/library/Site/Article/Processor.php on line 183

Notice: Undefined index: seconddigit in /usr2/unibs/library/Site/Article/Processor.php on line 183

Notice: Undefined index: seconddigit in /usr2/unibs/library/Site/Article/Processor.php on line 183

Notice: Undefined index: seconddigit in /usr2/unibs/library/Site/Article/Processor.php on line 183

Notice: Undefined index: seconddigit in /usr2/unibs/library/Site/Article/Processor.php on line 183

Notice: Undefined index: seconddigit in /usr2/unibs/library/Site/Article/Processor.php on line 183

Warning: file_get_contents(/usr2/data/content/bs/article/16/06/116012100191.json): failed to open stream: No such file or directory in /usr2/unibs/application/modules/article/controllers/ManagerController.php on line 1130

Warning: file_get_contents(/usr2/data/content/bs/article/16/06/116041600202.json): failed to open stream: No such file or directory in /usr2/unibs/application/modules/article/controllers/ManagerController.php on line 1130

Warning: file_get_contents(/usr2/data/content/bs/article/16/06/116042200439.json): failed to open stream: No such file or directory in /usr2/unibs/application/modules/article/controllers/ManagerController.php on line 1130

Warning: file_get_contents(/usr2/data/content/bs/article/16/06/116032301105.json): failed to open stream: No such file or directory in /usr2/unibs/application/modules/article/controllers/ManagerController.php on line 1130

Warning: file_get_contents(/usr2/data/content/bs/article/16/06/116032300628.json): failed to open stream: No such file or directory in /usr2/unibs/application/modules/article/controllers/ManagerController.php on line 1130